BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Nov 08, 2004
 |  BioCentury  |  Regulation

CMS grows its orphanage

CMS grows its orphanage

Drug Company Indication 2004 final 2005 proposed 2005 final 2004-05 % chg
Prolastin alpha-1 proteinase inhibitor Bayer Replacement therapy for alpha-1 proteinase inhibitor congenital deficiency $3.43 $2.46...

Read the full 223 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >